The majority of allergen-specific IgE in the blood of allergic patients does not originate from blood-derived B cells or plasma cells

Clinical and Experimental Allergy

Volumn 42, Issue 9, 2012, Pages 1347-1355

  Eckl Dorna, J ^a   Pree, I ^a   Reisinger, J ^a   Marth, K ^a,b   Chen, K W ^b   Vrtala, S ^b   Spitzauer, S ^a   Valenta, R ^a,b   Niederberger, V ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Basophils; CD138+ plasma cells; IgE synthesis; Specific IgE levels

Indexed keywords

ALLERGEN; ANTIGEN; BET V 1 ALLERGEN; CD19 ANTIGEN; CD20 ANTIGEN; CD203C ANTIGEN; CD22 ANTIGEN; CD27 ANTIGEN; CD38 ANTIGEN; DER P 2 ALLERGEN; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; INTERLEUKIN 6 RECEPTOR; MESSENGER RNA; PHL P 1 ALLERGEN; PHL P 5 ALLERGEN; POLLEN ANTIGEN; SYNDECAN 1; UNCLASSIFIED DRUG;

ALLERGY; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; BASOPHIL; BLOOD SAMPLING; CELL POPULATION; CELL SEPARATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GRASS POLLEN; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMA CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPERNATANT;

ALLERGENS; ANTIBODY SPECIFICITY; B-LYMPHOCYTES; CELLS, CULTURED; FLOW CYTOMETRY; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOGLOBULIN E; LEUKOCYTES, MONONUCLEAR; PLASMA CELLS; SYNDECAN-1;

EID: 84865611700     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2012.04030.x     Document Type: Article

References (35)

1. Kay AB, Kaplan A, Bousquet J, Holt B, eds. Allergy and allergic diseases, 2nd Edn. Oxford, England: Blackwell Publishing Ltd, 2008.
2. Bischoff SC. Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data. Nat Rev Immunol 2007; 7:93-104.
3. van Neerven RJJ, Knol EF, Ejrnaes A, Würtzen PA. IgE-mediated allergen presentation and blocking antibodies. Regulation of T-cell activation in allergy. Int Arch Allergy Immunol 2006; 141:119-29.
4. Maurer D, Ebner C, Reininger B et al. The high affinity IgE receptor (Fc epsilon RI) mediates IgE-dependent allergen presentation. J Immunol 1995; 154:6285-90.
5. Novak N, Bieber T, Peng WM. The immunoglobulin E-Toll-like receptor network. Int Arch Allergy Immunol 2010; 151:1-7.
6. MacGlashan D. Anti-IgE antibody therapy. Clin Allergy Immunol 2002; 16:519-32.
7. Hamilton RG, Adkinson NF Jr. 23. Clinical laboratory assessment of IgE-dependent hypersensitivity. J Allergy Clin Immunol 2003; 111:687-701.
8. Hirano T, Hom C, Ovary Z. Half life of murine IgE antibodies in the mouse. Int Arch Allergy Appl Immunol 1983; 71:182-4.
9. Henderson LL, Larson JB, Gleich GJ. Maximal rise in IgE antibody following ragweed pollination season. J Allergy Clin Immunol 1975; 55:10-5.
10. Niederberger V, Ring J, Rakoski J et al. Antigens drive memory IgE responses in human allergy via the nasal mucosa. Int Arch Allergy Immunol 2007; 142:133-44.
11. Steinberger P, Bohle B, di Padova F et al. Allergen-specific IgE production of committed B cells from allergic patients in vitro. J Allergy Clin Immunol 1995; 96:209-18.
12. Steinberger P, Kraft D, Valenta R. Construction of a combinatorial IgE library from an allergic patient. Isolation and characterization of human IgE Fabs with specificity for the major timothy grass pollen allergen, Phl p 5. J Biol Chem 1996; 271:10967-72.
13. Horst A, Hunzelmann N, Arce S et al. Detection and characterization of plasma cells in peripheral blood: correlation of IgE+ plasma cell frequency with IgE serum titre. Clin Exp Immunol 2002; 130:370-8.
14. Chvatchko Y, Kosco-Vilbois MH, Herren S, Lefort J, Bonnefoy JY. Germinal center formation and local immunoglobulin E (IgE) production in the lung after an airway antigenic challenge. J Exp Med 1996; 184:2353-60.
15. Durham SR, Gould HJ, Hamid QA. Local IgE production in nasal allergy. Int Arch Allergy Immunol 1997; 113:128-30.
16. KleinJan A, Vinke JG, Severijnen LW, Fokkens WJ. Local production and detection of (specific) IgE in nasal B-cells and plasma cells of allergic rhinitis patients. Eur Respir J 2000; 15:491-7.
17. Cameron L, Gounni AS, Frenkiel S, Lavigne F, Vercelli D, Hamid Q. S epsilon S mu and S epsilon S gamma switch circles in human nasal mucosa following ex vivo allergen challenge: evidence for direct as well as sequential class switch recombination. J Immunol 2003; 171:3816-22.
18. Coeffier M, Lorentz A, Manns MP, Bischoff SC. Epsilon germ-line and IL-4 transcripts are expressed in human intestinal mucosa and enhanced in patients with food allergy. Allergy 2005; 60:822-7.
19. Stern DA, Riedler J, Nowak D et al. Exposure to a farming environment has allergen-specific protective effects on TH2-dependent isotype switching in response to common inhalants. J Allergy Clin Immunol 2007; 119:351-8.
20. Chen KW, Fuchs G, Sonneck K et al. Reduction of the in vivo allergenicity of Der p 2, the major house-dust mite allergen, by genetic engineering. Mol Immunol 2008; 45:2486-98.
21. Twaroch TE, Focke M, Civaj V et al. Carrier-bound, nonallergenic Ole e 1 peptides for vaccination against olive pollen allergy. J Allergy Clin Immunol 2011; 128:178-84.
22. Grönlund H, Bergman T, Sandström K et al. Formation of disulfide bonds and homodimers of the major cat allergen Fel d 1 equivalent to the natural allergen by expression in Escherichia coli. J Biol Chem 2003; 278:40144-51.
23. H-gene families. Immunology 2000; 101:112-9.
24. Dolecek C, Steinberger P, Susani M, Kraft D, Valenta R, Boltz-Nitulescu G. Effects of IL-4 and IL-13 on total and allergen specific IgE production by cultured PBMCs from allergic patients determined with recombinant pollen allergens. Clin Exp Allergy 1995; 25:879-89.
25. Edwards MR, Brouwer W, Choi CH, Ruhno J, Ward RL, Collins AM. Analysis of IgE antibodies from a patient with atopic dermatitis: biased V gene usage and evidence for polyreactive IgE heavy chain complementarity-determining region 3. J Immunol 2002; 168:6305-13.
26. Andreasson U, Flicker S, Lindstedt M et al. The Human IgE-encoding Transcriptome to Assess Antibody Repertoires and Repertoire Evolution. J Mol Biol 2006; 362:212-27.
27. Marth K, Novatchkova M, Focke-Tejkl M et al. Tracing antigen signatures in the human IgE repertoire. Mol Immunol 2010; 47:2323-9.
28. Saarinen UM. Transfer of latent atopy by bone marrow transplantation? A case report. J Allergy Clin Immunol 1984; 74:196-200.
29. Agosti JM, Sprenger JD, Lum LG et al. Transfer of allergen-specific IgE-mediated hypersensitivity with allogeneic bone marrow transplantation. N Engl J Med 1988; 319:1623-8.
30. Bellou A, Kanny G, Fremont S, Moneret-Vautrin DA. Transfer of atopy following bone marrow transplantation. Ann Allergy Asthma Immunol 1997; 78:513-6.
31. Mei HE, Yoshida T, Sime W et al. Blood-borne human plasma cells in steady state are derived from mucosal immune responses. Blood 2009; 113:2461-9.
32. Trendelenburg M, Schifferli A. Rituximab in a Patient With Hyper-IgE Syndrome. Arch Dermatol 2007; 143:807-8.
33. Simon D, Hösli S, Kostylina G et al. Anti-CD20 (rituximab) treatment improves atopic eczema. J Allergy Clin Immunol 2008; 121:122-8.
34. Lupinek C, Roux KH, Laffer S et al. Trimolecular complex formation of IgE, Fc(epsilon)RI, and a recombinant nonanaphylactic single-chain antibody fragment with high affinity for IgE. J Immunol 2009; 182:4817-29.
35. Brightbill HD, Jeet S, Lin Z et al. Antibodies specific for a segment of human membrane IgE deplete IgE-producing B cells in humanized mice. J Clin Invest 2010; 120:2218-29.